TipRanks
Advertisement
Advertisement
Alzamend Neuro’s New Lithium Study Puts AL001 in the Bipolar Disorder Spotlight
PremiumCompany AnnouncementsAlzamend Neuro’s New Lithium Study Puts AL001 in the Bipolar Disorder Spotlight
3M ago
Alzamend Neuro Announces Passing of Board Director
Premium
Company Announcements
Alzamend Neuro Announces Passing of Board Director
3M ago
Alzamend Neuro Shareholders Approve Governance and Capital Measures
Premium
Company Announcements
Alzamend Neuro Shareholders Approve Governance and Capital Measures
6M ago
Alzamend Neuro Establishes ATM Equity Offering Agreement
PremiumCompany AnnouncementsAlzamend Neuro Establishes ATM Equity Offering Agreement
8M ago
Alzamend Neuro completes clinical portion of Phase II clinical study of AL001
Premium
The Fly
Alzamend Neuro completes clinical portion of Phase II clinical study of AL001
11M ago
Alzamend Neuro Mourns Loss of Director Andrew Woo
Premium
Company Announcements
Alzamend Neuro Mourns Loss of Director Andrew Woo
11M ago
Alzamend Neuro reports FY25 net cash provided by financing activities of $10.4M
PremiumThe FlyAlzamend Neuro reports FY25 net cash provided by financing activities of $10.4M
1y ago
Alzamend Neuro announces final closing of $5M private placement
Premium
The Fly
Alzamend Neuro announces final closing of $5M private placement
1y ago
Alzamend Neuro Stock (ALZN) Rockets 145% on Study Update
Premium
Market News
Alzamend Neuro Stock (ALZN) Rockets 145% on Study Update
1y ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―